JOINN Biologics US Inc.

JOINN Biologics US Inc. is a California Bay Area-based company that specializes in providing contract manufacturing and development services for biologics and advanced therapies. With a strong track record of over 20 years, the company offers a comprehensive range of services, including molecular/developability assessment, cGMP clinical trial materials production, commercial-scale cGMP manufacturing, and more, on a global scale. Amid the COVID-19 pandemic, JOINN Biologics remains committed to the health and safety of its community and employees while staying dedicated to its mission. The company aims to accelerate the development of high-quality biologics to meet patients' needs and deliver lasting value to the biotech and biopharmaceutical industry. Founded in 2018, the company operates in the Biopharma, Biotechnology, and Manufacturing sectors, with its headquarters in the United States. In August 2021, JOINN Biologics secured a $150.00M Series B investment from a group of investors, including Green Pine Capital Partners, HongTao Capital, Huagai Capital, CPE, 盈科创新资产管理有限公司, and Aplus Capital. To foster its growth in the biotech and biopharmaceutical CDMO field, the company emphasizes its people, values, and culture, focusing on technical expertise, timely communication, collaboration, and innovation. For those interested in becoming part of the JOINN team, job openings and news can be found on their website.